NATALIE HANES: Open Payments
NPI 1699145862 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 54 payments from 9 companies in 2025. Trend: 2023 $920 · 2024 $816 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $455 |
| Vanda Pharmaceuticals Inc. | 13 | $207 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| Alkermes, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $36 |
| ABBVIE INC. | 1 | $32 |
Products named: CAPLYTA, FANAPT, INVEGA SUSTENNA, ARISTADA, REXULTI, ABILIFY MAINTENA, Auvelity, INGREZZA.
Industry payments across CA — which companies pay providers there.
